Myomo Inc (MYO)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $49.32M
Last updated: Nov 17, 2026 at 11:05 AM ET
Myomo Inc (MYO) Stock Forecast
Analysts expect Myomo (MYO) to earn -$0.33 per share in the fiscal year ending Dec 31, 2026, on revenue of $46.49M. Of 5 analysts, 5 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 1.80, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 4 | 80.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 9.9%.
- Fiscal year ending Dec 31, 2026
- -$0.33
- EPS consensus, revenue $46.49M
- Fiscal year ending Dec 31, 2027
- -$0.22
- EPS consensus, revenue $51.10M
- Next report
- Mar 8, 2027
- Confirmed, after the close
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.33 | -$0.34 to -$0.32 | 4 | $46.49M | $46.26M to $46.63M | 4 |
| Dec 31, 2027 | -$0.22 | -$0.26 to -$0.16 | 4 | $51.10M | $47.00M to $54.48M | 5 |
Quarterly Estimates
The EPS consensus falls from -$0.07 for the quarter ending Dec 31, 2026 to -$0.08 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.07 | -$0.08 to -$0.06 | 6 | $12.32M | $11.37M to $13.10M | 6 |
| Mar 31, 2027 | -$0.08 | -$0.10 to -$0.06 | 3 | $10.94M | $9.50M to $11.71M | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 7 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 1 |
| Fiscal year ending Dec 31, 2027 | 3 | 0 |
| Quarter ending Mar 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.30.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.33 | -$0.31 | -$0.31 | -$0.31 | -$0.30 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.22 | -$0.22 | -$0.22 | -$0.22 | -$0.23 | N/A |
| Quarter ending Mar 31, 2027 | -$0.08 | -$0.07 | -$0.07 | -$0.07 | -$0.08 | N/A |
Frequently Asked Questions About MYO
What is the MYO stock forecast?
Consensus analyst estimates put Myomo's EPS at -$0.33 for the fiscal year ending Dec 31, 2026, on revenue of $46.49M. The consensus rating from 5 analysts is Buy.
How do analysts rate MYO stock?
Of 5 analysts covering Myomo, 1 rates it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from MYO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.33, with estimates from -$0.34 to -$0.32 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.22, with estimates from -$0.26 to -$0.16 from 4 analysts.
What revenue do analysts expect from Myomo next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $46.49M, with estimates from $46.26M to $46.63M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $51.10M, with estimates from $47.00M to $54.48M.
How many analysts cover MYO?
5 analysts rate Myomo stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
MYO pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts